Implementation of the global risk analysis in pulsed-dose rate brachytherapy: Methods and results

被引:2
|
作者
Mazeron, R. [1 ]
Aguini, N. [2 ]
del Campo, E. Rivin [1 ]
Dumas, I. [3 ]
Gensse, M. -C. [1 ]
Brusadin, G. [1 ]
Lefkopoulos, D. [3 ]
Deutsch, E. [1 ]
Haie-Meder, C. [1 ]
机构
[1] Gustave Roussy Canc Campus Grand Paris, Radiat Oncol, F-97805 Villejuif, France
[2] Gustave Roussy Canc Campus Grand Paris, Qual & Risk Assessment, F-97805 Villejuif, France
[3] Gustave Roussy Canc Campus Grand Paris, Med Phys, F-97805 Villejuif, France
来源
CANCER RADIOTHERAPIE | 2015年 / 19卷 / 02期
关键词
Pulsed-dose rate brachytherapy; Safety; Risk assessment; Global risk analysis; Mapping; RADIATION-THERAPY; FAILURE MODE; RADIOTHERAPY; TECHNOLOGIES; SAFETY; SYSTEM; CARE;
D O I
10.1016/j.canrad.2014.11.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose. - To report the application of the global risk analysis (GRA) in the pulsed-dose rate (PDR) brachytherapy workflow. Material and Methods. - Analyses were led by a multidisciplinary working group established within the unit with the guidance of a quality engineer. First, a mapping of hazardous situations was developed as a result of interactions between the patient workflow for a treatment using PDR brachytherapy split into 51 sub-phases with a comprehensive list of the hazards that he/she faces (44). Interactions, when relevant, were sorted by level of priority: to be treated immediately, secondarily (the group is not entitled to treat the situation), or later (safe situation). Secondly, for each high priority dangerous situation, scenarios were developed to anticipate their potential consequences. Criticality was assessed, using likelihood and severity scales and a matrix, which allocated risks into categories: acceptable (C1), tolerable under control (C2) and unacceptable (C3). Then, corrective actions were proposed and planned when relevant, after assessment of their feasibility with a scale of effort. Finally, the criticality of the scenarios was reevaluated, taking into account the implementation of these actions, leading to a residual risk mapping, which could trigger additional proposals of actions. Results. - Two thousand one hundred and eighty-four potential interactions between the list of hazards and the workflow were analyzed. Mapping of dangerous situations identified 213 relevant interactions, from which 61 were considered with high priority. One hundred and twenty-six scenarios were generated: 68 with a low criticality (74.3%), 58 with an intermediate score (25.7%). No scenario with the highest criticality was individualized. Twenty-one corrective actions were planned. Mapping of residual risk resulted in the disappearance of most C2 risks, leaving 5 C2 scenarios (4%), for which four monitoring indicators were implemented in addition to the corrected actions decided on. Conclusion. - The implementation of the GRA appeared feasible, and led to implement 21 corrective actions, based on scenarios and not on incidents. (C) 2015 Societe francaise de radiotherapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:89 / 97
页数:9
相关论文
共 50 条
  • [1] Pulsed-Dose Rate Brachytherapy for the Treatment of Endometrial Cancer
    De Felice, Francesca
    Caiazzo, Rossella
    Benevento, Ilaria
    Musio, Daniela
    Rubini, Filippo
    Tombolini, Vincenzo
    ONCOLOGY, 2017, 92 (06) : 311 - 316
  • [2] Pulsed-dose rate brachytherapy in cervical cancers: Why, how?
    Mazeron, R.
    Dumas, I.
    Martin, V.
    Martinetti, F.
    Benhabib-Boukhelif, W.
    Gensse, M. -C.
    Chargari, C.
    Guemnie-Tafo, A.
    Haie-Meder, C.
    CANCER RADIOTHERAPIE, 2014, 18 (5-6): : 447 - 451
  • [3] Pulsed-dose rate brachytherapy for pediatric bladder prostate rhabdomyosarcoma: Compliance and early clinical results
    Chargari, Cyrus
    Martelli, Helene
    Guerin, Florent
    Bacorro, Warren
    de lambert, Guenolee
    Escande, Alexandre
    Minard-Colin, Veronique
    Dumas, Isabelle
    Deutsch, Eric
    Haie-Meder, Christine
    RADIOTHERAPY AND ONCOLOGY, 2017, 124 (02) : 285 - 290
  • [4] Measurement verification of dose distributions in pulsed-dose rate brachytherapy in breast cancer
    Mantaj, Patrycja
    Zwierzchowski, Grzegorz
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2013, 18 (03) : 139 - 147
  • [5] Pulsed dose rate brachytherapy
    Alfredo Polo
    Clinical and Translational Oncology, 2008, 10
  • [6] Pulsed dose rate brachytherapy
    Polo, Alfredo
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2008, 10 (06): : 324 - 333
  • [7] Pulsed-dose rate image-guided adaptive brachytherapy in cervical cancer: Dose-volume effect relationships for the rectum and bladder
    Mazeron, Renaud
    Maroun, Pierre
    Castelnau-Marchand, Pauline
    Dumas, Isabelle
    del Campo, Eleonor Rivin
    Cao, Kim
    Slocker-Escarpa, Andrea
    M'Bagui, Rodrigue
    Martinetti, Florent
    Tailleur, Anne
    Guemnie-Tafo, Alain
    Morice, Philippe
    Chargari, Cyrus
    Lefkopoulos, Dimitri
    Haie-Meder, Christine
    RADIOTHERAPY AND ONCOLOGY, 2015, 116 (02) : 226 - 232
  • [8] Pulsed dose-rate brachytherapy
    Hall, EJ
    Brenner, DJ
    RADIOTHERAPY AND ONCOLOGY, 1997, 45 (01) : 1 - 2
  • [9] High-dose-rate brachytherapy and pulsed brachytherapy
    Mazeron, JJ
    EUROCANCER 2002, 2002, : 57 - 58
  • [10] Quality control in pulsed dose rate brachytherapy
    Metayer, Y.
    Meyer, P.
    Brunaud, C.
    Peiffert, D.
    CANCER RADIOTHERAPIE, 2009, 13 (04): : 318 - 322